Regulation and role of IFN-γ in the innate resistance to infection with Chlamydia pneumoniae

Journal of Immunology

Volumn 164, Issue 9, 2000, Pages 4812-4818

  Rottenberg, Martín E ^a   Rothfuchs, Antonio Gigliotti ^a   Gigliotti, Dulceaydee ^a   Ceausu, Monica ^a   Une, Clas ^a   Levitsky, Victor ^a   Wigzell, Hans ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; MESSENGER RNA; NITRIC OXIDE; PERFORIN;

ANIMAL EXPERIMENT; ARTICLE; BACTERICIDAL ACTIVITY; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOKINE RELEASE; FEEDBACK SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; INFECTION RESISTANCE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0034193992     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.9.4812     Document Type: Article

References (43)

1. Kuo, C. C., A. Shor, L. A. Campbell, H. Fukushi, D. L. Patton, and J. T. Grayston. 1993. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 167:841.
2. Gupta, S., E. Leatham, D. Carrington, M. Mendall, J. Kaski, and A. Camm. 1997. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 96:404.
3. Muhlestein, J. B., J. L. Anderson, E. H. Hammond, L. P. Zhao, S. Trehan, E. P. Schwobe, and J. F. Carlquist. 1998. infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97:633.
4. Taylor-Robinson, D., G. Ong, B. J. Thomas, M. L. Rose, and M. H. Yacoub. 1998. Chlamydia pneumoniae in vascular tissues from heart-transplant donors. Lancet 351:1255.
5. Yang, Z. P., C. C. Kuo, and J. T. Grayston. 1993. A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis. Infect. Immun. 61:2037.
6. Rottenberg, M. E., A. C. Gigliotti-Rothfuchs, D. Gigliotti, C. Svanholm, L. Bandholtz, and H. Wigzell. 1999. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J. Immunol. 162:2829.
7. Trinchieri, G. 1998. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70:83.
8. Oxenius, A., U. Karrer, R. M. Zinkernagel, and H. Hengartner. 1999. 1L-12 is not required for induction of type 1 cytokine responses in viral infections. J. Immunol. 162:965.
9. Mayer, J., M. L. Woods, Z. Vavrin, and J. Hibbs, Jr. 1993. γ Interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells. Infect. Immun. 61:491.
10. Johansson, M., K. Sehon, M. Ward, and N. Lycke. 1997. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in γ interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect. Immun. 65:1032.
11. Beatty, W. L., G. I. Byrne, and R. P. Morrison. 1993. Morphologic and antigenic characterization of interferon γ-mediated persistent Chlamydia trachomatis infection in vitro. Proc. Natl. Acad. Sci. USA 90:3998.
12. Carlin, J. M., E C. Borden, P. M. Sondel, and G. I. Byrne. 1987. Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures. J. Immunol. 139:2414.
13. Werner, E. R., G. Werner-Felmayer, D. Fuchs, A. Hausen, G. Reibnegger, and H. Wachter. 1989. Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-γ. Biochem. J. 262:861.
14. Hassanain, H. H., S. Y. Chon, and S. L. Gupta. 1993. Differential regulation of human indoleamine 2,3-dioxygenase gene expression by interferons -γ and -α: analysis of the regulatory region of the gene and identification of an interferon-γ-inducible DNA-binding factor. J. Biol. Chem. 268:5077.
15. Carlin, J. M., and J. B. Weller. 1995. Potentiation of interferon-mediated inhibition of Chlamydia infection by interleukin-1 in human macrophage cultures. Infect. Immun. 63:1870.
16. Summersgill, J. T., N. N. Sahney, C. A. Gaydos, T. C. Quinn, and J. A. Ramirez. 1995. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with γ interferon and tumor necrosis factor α. Infect. Immun. 63:2801.
17. Beatty, W. L., T. A. Belanger, A. A. Desai, R. P. Morrison, and G. I. Byrne. 1994. Tryptophan depletion as a mechanism of γ interferon-mediated chlamydial persistence. Infect. Immun. 62:3705.
18. Thomas, S., L. Garrity, C. Brandt, S. Shobert, G. Feng, M. Taylor, J. Carlin, and G. Byrne. 1993. IFN-γ-mediated antimicrobial response: indoleamine 2,3 dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth. J. Immunol. 150:5529.
19. Mehta, S. J., R. D. Miller, J. A. Ramirez, and J. T. Summersgill. 1998. Inhibition of Chlamydia pneumoniae replication in hep-2 cells by interferon-γ: role of tryptophan catabolism. J. Infect. Dis. 177:1326.
20. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323.
21. Igietseme, J. U., I. M. Uriri, M. Chow, E. Abe, and R. G. Rank. 1997. Inhibition of intracellular multiplication of human strains of Chlamydia trachomatis by nitric oxide. Biochem. Biophys. Res. Comm. 232:595.
22. Igietseme, J. U., L. L. Perry, G. A. Ananaba, I. M. Uriri, O. O. Ojior, S. N. Kumar, and H. D. Caldwell. 1998. Chlamydial infection in induciblc nitric oxide synthase knockout mice. Infect. Immun. 66:1282.
23. Chen, B., R. Stout, and W. F. Campbell. 1996. Nitric oxide production: a mechanism of Chlamydia trachomatis inhibition in interferon-γ-treated RAW264.7 cells. FEMS Immunol. Med. Microbiol. 14:109.
24. Cassatella, M. A., F. Bazzoni, R. M. Flynn, S. Dusi, G. Trinchieri, and F. Rossi. 1990. Molecular basis of interferon-γ and lipopolysaccharide enhancement of phagocyte respiratory burst capability: studies on the gene expression of several NADPH oxidase components. J. Biol. Chem. 265:20241.
25. Klebanoff, S. J., S. Olszowski, W. C. Van Voorhis, J. A. Ledbetter, A. M. Waltersdorph, and K. G. Schlechte. 1992. Effects of γ-interferon on human neutrophils: protection from deterioration on storage. Blood 80:225.
26. Huang, S., W. Hendricks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-γ receptor. Science 259:1742.
27. Kagi, D., B. Lederman, K. Burki, P. Seiler, B. Odermatt, K. Olsen, E. Poldack, R. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
28. Mombaerts, P., J. Iacomini, R. Johnson, K. Herrup, S. Tonegawa, and V. Papaioannou. 1992. RAG-1 deficient mice have no mature T and B lymphocytes. Cell 68:869.
29. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. 1L-12-deficient mice are defective in IFN γ production and type 1 cytokine responses. Immunity 4:471.
30. Rottenberg, M. E., E. Castaños-Velez, R. de Mesquita, O. G. Laguardia, P. Biberfeld, and A. Örn. 1996. Intracellular co-localization of Trypanosoma cruzi and inducible nitric oxide synthase (iNOS): evidence for dual pathway of iNOS induction. Eur. J. Immunol. 26:3203.
31. Siebert, P. D., and J. W. Larrick. 1992. Competitive PCR. Nature 359:557.
32. Yin, Z. H., J. Braun, L. Neure, P. H. Wu, L. Z. Liu, U. Eggens, and J. Sieper. 1997. Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum. 40: 1788.
33. Perry, L. L., K. Feilzer, and H. D. Caldwell. 1997. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-γ-dependent and -independent pathways. J. Immunol. 158:3344.
34. Huang, J., M. D. Wang, S. Lenz, D. Gao, and B. Kaltenboeck. 1999. 1L-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue. J. Immunol. 162:2217.
35. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045.
36. Ma, X., J. M. Chow, G. Gri, G. Carra, F. Gerosa, S. F. Wolf, R. Dzialo, and G. Trinchieri. 1996. The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J. Exp. Med. 183:147.
37. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
38. Issekutz, A. C., and T. B. Issekutz. 1993. Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-1 α, tumor necrosis factor-α, and IFN-γ. J. Immunol. 151:2105.
39. Oliveira, I. C., N. Mukaida, K. Matsushima, and J. Vilcek. 1994. Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-κB site. Mol. Cell. Biol. 14:5300.
40. Taub, D. D., A. R. Lloyd, K. Conlon, J. M. Wang, J. R. Ortaldo, A. Harada, K. Matsushima, D. J. Kelvin, and J. J. Oppenheim. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177:1809.
41. Onsrud, M., and E. Qvigstad. 1984. Natural killer cell activity after gynecologic infections with chlamydia. Acta Obstet. Gynecol. Scand. 63:613.
42. Tseng, C. T., and R. G. Rank. 1998. Role of NK cells in early host response to chlamydial genital infection. Infect. Immun. 66:5867.
43. Wang, J., J. Wakeham, R. Harkness, and Z. Xing. 1999. Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J. Clin. Invest. 103:1023.